Cyclerion Therapeutics Appoints Errol De Souza, Ph.D., to Board of Directors

Ads

You May Also Like

Immunocore strengthens IP position in the field of TCR-based therapeutics

PRESS RELEASE Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of ...

Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales

MALVERN, Pa., May 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage ...